146 related articles for article (PubMed ID: 25054131)
1. Rank-based miRNA signatures for early cancer detection.
Lauria M
Biomed Res Int; 2014; 2014():192646. PubMed ID: 25054131
[TBL] [Abstract][Full Text] [Related]
2. Rank-based miRNA signatures for blood-based diagnosis of tuberculosis.
Lauria M
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():4462-5. PubMed ID: 26737285
[TBL] [Abstract][Full Text] [Related]
3. Considerations for feature selection using gene pairs and applications in large-scale dataset integration, novel oncogene discovery, and interpretable cancer screening.
Moody L; Chen H; Pan YX
BMC Med Genomics; 2020 Oct; 13(Suppl 10):148. PubMed ID: 33087122
[TBL] [Abstract][Full Text] [Related]
4. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
5. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling of male breast cancer.
Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A
Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.
Lyng MB; Kodahl AR; Binder H; Ditzel HJ
Mol Oncol; 2016 Dec; 10(10):1621-1626. PubMed ID: 27839676
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA: A signature for cancer progression.
Hussen BM; Hidayat HJ; Salihi A; Sabir DK; Taheri M; Ghafouri-Fard S
Biomed Pharmacother; 2021 Jun; 138():111528. PubMed ID: 33770669
[TBL] [Abstract][Full Text] [Related]
10. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
11. SCUDO: a tool for signature-based clustering of expression profiles.
Lauria M; Moyseos P; Priami C
Nucleic Acids Res; 2015 Jul; 43(W1):W188-92. PubMed ID: 25958391
[TBL] [Abstract][Full Text] [Related]
12. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
13. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNA panels for specific and early detection in bladder cancer.
Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T
Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619
[TBL] [Abstract][Full Text] [Related]
16. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
17. miRNA profiling of cancer.
Di Leva G; Croce CM
Curr Opin Genet Dev; 2013 Feb; 23(1):3-11. PubMed ID: 23465882
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
19. Current State of Circulating MicroRNAs as Cancer Biomarkers.
He Y; Lin J; Kong D; Huang M; Xu C; Kim TK; Etheridge A; Luo Y; Ding Y; Wang K
Clin Chem; 2015 Sep; 61(9):1138-55. PubMed ID: 26319452
[TBL] [Abstract][Full Text] [Related]
20. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
